Connect with us

Business

ViaDerma: Expanding Innovative Transdermal Technology Solutions to $366 Billion Global Markets

Published

on

In the ever-evolving world of medicine, innovations are constantly emerging to improve patient care and outcomes. One such breakthrough comes from ViaDerma, a pharmaceutical company that has developed a groundbreaking transdermal delivery technology by transforming oral medications into potent topical ointments for rapid, targeted results.

Founded in 2014 by Dr. Christopher Otiko, ViaDerma is committed to providing advanced solutions to the healthcare industry for wound care treatments and a variety of infectious skin diseases, while targeting several global markets worth over $366 billion and growing.

In this exclusive interview, we delve into the secrets behind ViaDerma’s cutting-edge technology, the unique features of their lead product, Vitastem Ultra, and the company’s plans for expanding its impact on global markets.

Interview with ViaDerma’s CEO, Dr. Christopher Otiko

What industries do you license your transdermal technology to?

We currently offer our proprietary transdermal technology licensing to leaders within the pharmaceutical, wound care, pet care, and cosmetics industries. Our wound care and infectious skin disease solutions are targeted to helping hospitals, surgery centers, nursing homes, wound care facilities, to veterinarians, sports injuries, and more treat and heal infectious skin diseases to surgical & diabetic wounds too.

What makes your product offerings so special?

A few things, but it’s really all about the chemistry. You see, unlike pretty much all known antibiotics that primarily use what’s referred to as a chemical “mechanism of kill” only, whereby the antibiotic attempts to kill the bacteria slowly by applying more and more of the medicine over a period of time as it is taken as prescribed, whether it’s topical or orally administered. Although this method can be somewhat effective, it takes much longer to perform. Unfortunately, this process allows for bacteria to evolve and develop a resistance to the medicine.

This is where our proprietary transdermal technology behind a product like Vitastem Ultra is different, in that is uses both a chemical and a physical mechanism to fight and kill pathogens. The physical mechanism of kill is a key feature of Vitastem’s strength.

What are a few key product differentiators?

There are many, but here are a few of them…

  • Vitastem Ultra is the only antibiotic in the world that kills with both a physical and chemical mechanism, giving it a unique ability to defeat drug resistant bacteria.
  • Vitastem Ultra kills all known bacteria it has ever been tested against, including common antibiotic-resistant MRSA (flesh-eating bacteria) and Staph Infection.
  • Vitastem Ultra has saved countless patients from amputations, while helping to reduce their hospital stays and increase their life expectancy.
  • Vitastem Ultra has a unique ability to heal and regenerate tissue unlike any other medication on the market.
  • Vitastem Ultra is safe to use for any age group. It’s a Class-1 medical product (in the safest of medical categories) and available for over the counter (OTC). Plus, being a topical antibiotic, it will not harm the kidneys or the good bacteria in the stomach, unlike oral antibiotics.

How did you get started in the medical field?

I got my BS in Biochemistry at Ilorin University in Ilorin, Nigeria. After that, I went on to get my master’s degree in Biochemistry at Oklahoma State University, Stillwater OK. Then, I went on to attend what was then called the California College of Podiatric Medicine in San Francisco, CA where I obtained my Doctor of Podiatric Medicine degree.

Where did you grow up?

I was born in Nigeria, but I left there when I was about 3 years old. I was raised in London, England and lived there until I was 14. I then moved back to Nigeria where I lived for about 8 more years. While deciding to go chase the “American Dream,” I ended up moving to the US when I was 22 to attend graduate school.

How does ViaDerma plan on penetrating your target global markets?

We’re already pretty active in doing so with targeting our solutions to wound care networks nationwide, along with pursuing opportunities with many hospitals, surgical centers, and universities too. We are in the process of ramping up sales staff and recently hired a top marketing agency to help with brand development and growing the business online too.

The Next Steps for ViaDerma

ViaDerma is revolutionizing the treatments for infectious skin diseases and wound care through its innovative transdermal delivery technology system. The company’s lead product, Vitastem Ultra, boasts numerous unique advantages, including its dual chemical and physical mechanisms of action, its ability to kill all known bacteria it has been tested against, and its skin tissue regeneration capabilities.

With a growing commitment to providing advanced solutions to a wide range of industries, including pharmaceuticals, wound care, pet care, and cosmetics, ViaDerma is poised to make a significant impact in several global markets. In addition to these markets, ViaDerma recently announced they will be unveiling a far more advanced hair regrowth formula, Nupelo, which will compete with leading brands on a global scale in 2023. Nupelo will use 5% minoxidil as the active ingredient, along with ViaDerma’s proprietary transdermal delivery system, as they feel this will be the most advanced hair restoration product on the market soon. Not only will it help people reduce their hair falling out, but it will also help regrow their hair too.

The company’s founder, Dr. Christopher Otiko, brings a wealth of experience and passion to the field, with a focus on improving patient outcomes and reducing the risk of complications such as amputations. As ViaDerma continues to grow, it aims to penetrate its target global markets by partnering with wound care networks, hospitals, surgical centers, and universities.

By expanding its sales staff and collaborating with a top marketing agency, ViaDerma is well-positioned to transform the landscape for treating infectious skin diseases and wound care on a global scale.

By offering a powerful, effective, and safe alternative to traditional antibiotics, ViaDerma has the potential to change the way we approach treating skin infections and wounds, especially antibiotic-resistant bacteria like MRSA (flesh-eating bacteria) and staph infection, which are common HAIs (healthcare-acquired infections) that results in millions of needless infections, hundreds of thousands of deaths, and billions of dollars in excess costs to healthcare.

This innovative company is not only pushing the boundaries of current medical technology, but it is also committed to improving the lives of countless patients worldwide. With its unique transdermal technology and dedication to excellence, ViaDerma is quickly becoming an essential player in the future of medicine and health care for billions.

This article contains branded content provided by a third party. The views expressed in this article are solely those of the content creator or sponsor and do not necessarily reflect the opinions or editorial stance of Popular Hustle.

Business

Miixed Realities Proves Medical Billing Doesn’t Have to Be a Black Hole

Published

on

Miixed Realities

For most clinics, the revenue cycle feels like throwing money into a void. Claims go out, denials pile up, and thousands of dollars sit in accounts receivable while practices wonder what’s actually happening. It’s a problem Gianni Gonzalez heard about repeatedly before founding Miixed Realities.

The company started from a conversation with a doctor in Hawaii who described the same billing headaches Gonzalez kept hearing from practices nationwide. Different states, different specialties, same struggle. “Patient care was never the problem. Billing was,” Gonzalez says. What clinics needed wasn’t more software. They needed experienced people who actually knew how to work claims from start to finish.

That’s where the company comes in. Miixed Realities, a leading medical billing office in El Paso, Texas, places HIPAA-certified, US-based billers directly inside a clinic’s existing electronic health records system and manages the full revenue cycle. Every claim runs through an in-house AI verification system before submission, and denied or unpaid claims get actively worked until they’re resolved. The pricing is straightforward: $5 per processed bill plus 6% of successfully recovered claims. No setup fees, no monthly retainers, no long-term contracts.

The company reports strong results. According to Miixed Realities, one pediatric clinic recovered $60,000 in just two weeks, and practices typically see 30% higher collections within weeks of onboarding. More than five practices have replaced their offshore teams with the company’s US-based billers. Miixed Realities integrates with over 50 practice management systems, including AthenaHealth, Kareo, Epic, and Cerner, and says it can have a practice up and running within 48 to 72 hours.

What sets them apart from offshore providers, according to the founder, is attention to detail and direct communication during US business hours. The company maintains 95-98% clean-claim rates and processes claims within 24 hours. Clients get full visibility through a real-time dashboard that tracks pending submissions, approved claims, denial statuses, and recovered revenue.

Miixed Realities is expanding its internal verification technology and onboarding specialty-specific billing teams. Practices nationwide can request a full audit to see exactly where revenue is being missed. It all goes back to that initial realization: clinics shouldn’t lose revenue because of preventable billing issues. With the right people and systems, they don’t have to.

Learn more at Miixed Realities or connect on LinkedIn and Instagram.

Continue Reading

Business

Inside the Amazon Reinstatement Process: The aSellingSecrets Approach

Published

on

When an Amazon seller account is suspended, confusion often sets in immediately. Automated messages, vague policy references, and limited communication channels make it difficult for sellers to understand what went wrong, let alone how to fix it. aSellingSecrets was created to bring clarity and structure to this process through a methodical approach to Amazon account reinstatement.

The reinstatement process at aSellingSecrets begins with a comprehensive account audit. Instead of responding directly to Amazon’s first notification, the team reviews seller performance metrics, historical warnings, prior appeals, listing activity, and operational workflows. This deeper analysis helps identify not only the stated reason for suspension, but also contributing factors that Amazon may not explicitly mention.

Once the root causes are identified, the team develops a tailored reinstatement strategy. This strategy is not limited to a single appeal submission. It includes corrective actions, operational adjustments, and communication sequencing designed to align with Amazon’s internal review process. The goal is to demonstrate accountability, compliance awareness, and long-term risk reduction, factors Amazon consistently prioritizes during reinstatement reviews.

A key component of the aSellingSecrets process is professional appeal creation. Each appeal is written with precision, focusing on facts rather than emotion. Clear explanations, structured corrective measures, and forward-looking prevention steps are combined to present a strong, credible case. This approach avoids common mistakes such as over-explaining, assigning blame, or submitting incomplete responses.

For complex or prolonged cases, aSellingSecrets leverages its professional attorney network in both the U.S. and EU. Legal insight is especially valuable in cases involving intellectual property claims, repeated suspensions, or compliance escalations. This added layer of expertise strengthens appeals and ensures alignment with regional regulations, and with 97% Success Rate on across all-time appeals.

Throughout the process, sellers are kept informed with realistic expectations. Reinstatement is rarely instant, and timelines can range from weeks to several months depending on the severity of the issue. aSellingSecrets emphasizes consistency and persistence, continuing to refine and submit responses when necessary until Amazon reaches a final decision.By combining structured analysis, strategic communication, and professional expertise, aSellingSecrets has built a reinstatement process designed for long-term success. Rather than offering quick fixes, the agency focuses on restoring seller accounts in a way that reduces future risk and helps businesses move forward with confidence.

(888) 503-1388
customercare@asellingsecrets.com
business@asellingsecrets.com
www.asellingsecrets.com

Continue Reading

Business

Young Romanian Entrepreneur Explores Lisbon’s Thriving Startup Scene

Published

on

André Marquet & Darius Borda

There’s a certain kind of clarity that comes from stepping outside your comfort zone. For Darius Borda, a young Romanian entrepreneur, that moment arrived in Lisbon, where he spent months collaborating with André Marquet, founder and CEO of Productized. What started as an exploration of Portugal’s tech ecosystem turned into something more concrete: the groundwork for his next business venture.

Borda didn’t just observe. He participated. He got involved in startup accelerators, the Productized Conference, the EUDIS Defence Hackathon, and the Lisbon GenAI Meetups, an exclusive community of AI specialists. It’s the kind of immersive experience that can’t be replicated from a distance.

André Marquet

“I came to Lisbon curious about entrepreneurship,” Borda said. “I left with new connections and the confidence to take the leap on my new business venture. Collaborating with André Marquet and being surrounded by people creating and launching their ideas was the best kind of learning.”

The collaboration worked both ways. Marquet found value in Borda’s IT management background and business instincts. “Collaborating with Darius Borda has been highly valuable,” Marquet noted. “His IT management expertise was essential to the organization of the Productized Conference, and his strong business acumen enabled meaningful deep-dives into entrepreneurial opportunities of mutual interest.”

Darius Borda

Beyond the formal events, the real work happened in conversations about defence tech, entrepreneurship, and early-stage startup ideas. Those discussions haven’t ended. There’s talk of future collaborations, though nothing’s set in stone yet.

The experience gave Darius Borda something he didn’t have before: a clearer sense of what’s next and the foundation to build on it. Sometimes that’s what you need. Not answers, just enough clarity to start.

Continue Reading
Advertisement
Follow Us - Popular Hustle on Spotify
Follow Us - Popular Hustle on Spotify
Follow Us - Popular Hustle on Spotify

Trending